If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary ... of unique prescribers, new patient prescriptions, refill ...

Verona filed for approval of ensifentrine ... to become the first in a new class of COPD therapies, providing bronchodilation and anti-inflammatory properties in one drug. Pooled data from the ...

The US Food and Drug Administration (FDA) has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in 2024. On 15 January, the two agencies ...

Apogee’s pipeline products include APG777, APG808, APG990, and APG222, that are being developed for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma ...

9. Ohtuvayre (ensifentrine) for COPD: Approved June 26, the inhaled medication is the first new type of maintenance COPD drug in over a decade. 10. Wakix (pitolisant) for pediatric narcolepsy ...

to the most approved drugs with a new active substance in 2024. On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs that ...

Initially approved in November 2023 for weight management in obese or overweight individuals, Zepbound’s new indication highlights its broader therapeutic potential. The drug is designed to be ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

When it was approved by the FDA in June ... moderate or severe exacerbations among COPD patients. Amgen and AstraZeneca have hopes for their asthma drug Tezspire as a potential COPD treatment.

That includes the approval of "innovative" drugs like Tryvio for high blood pressure, Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), which all ...